OrbiMed Advisors LLC

OrbiMed is one of the largest and most successful asset management firms focused exclusively on the global healthcare industry. OrbiMed's investment advisory activities began under the direction of Samuel D. Isaly in 1989. The firm currently manages over $3 billion in assets across a series of investment vehicles. OrbiMed's vision is that through investing across the entire spectrum of the global life sciences industry, from start-up biotechnology companies to large integrated pharmaceutical companies, the firm will be able to generate superior capital appreciation for our investors.

The hallmark of OrbiMed's investment process is rigorous, "bottom-up" industry research, which is conducted by our extensive, diverse group of 14 investment professionals. The research staff currently includes 5 professionals with advanced scientific and/or medical degrees, which provides OrbiMed with a unique competitive advantage given the highly technical nature of the life sciences sector. Where it is appropriate, OrbiMed is active in supporting invested companies on both operational and strategic issues.

Contact Details: United States of America Tel: Fax: Email: WWW: www.orbimed.com/

Press Releases on OrbiMed Advisors LLC:
NxStage Reports Second Quarter 2008 Financial Results	5th August, 2008	NxStage Medical, Inc.	LAWRENCE, Mass., Aug. 5 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its financial results for the second
NxStage Completes Final Closing of Previously Announced Private Placement of Common Stock	1st August, 2008	NxStage Medical, Inc.	LAWRENCE, Mass., Aug. 1 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, announced today that it has completed its previously
NxStage Appoints Jonathan Silverstein to Board of Directors	24th July, 2008	NxStage Medical, Inc.	LAWRENCE, Mass., July 24 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the addition of Jonathan

BioNews Results for OrbiMed Advisors LLC:
Inhibitex to raise $23 million through private placement	News-Medical.Net:  Oct 24 2009 5:36AM Matching: orbimed advisors llc
Inhibitex, Inc. (INHX) Announces Equity Financing of $23 Million	BioSpace:  Oct 23 2009 4:31PM Matching: orbimed advisors llc
Amarin announces completion of $70 million private placement	Bionity.com:  Oct 20 2009 10:21AM Matching: orbimed advisors llc
Amarin Announces Completion of $70 Million Private Placement	Pharmacy Choice:  Oct 19 2009 9:22PM Matching: orbimed advisors llc
Amarin Announces Completion of $70 Million Private Placement	SmartBrief:  Oct 19 2009 3:09PM Matching: orbimed advisors llc
Promote your company here: BioNewsCast - Press Release Distribution	→View more OrbiMed Advisors LLC news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 468 times since April 2007, the link to the organisation's website has been followed 137 times

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for OrbiMed Advisors LLC